Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Debruyne

Showing results (1-10 of 505) with videos related to

Pageof 51
Sort By:
World Journal of Urology|June 21, 2002
Future aspects of TUMT treatment of benign prostatic hypertrophyF M Debruyne
Urology|November 14, 2000
Alpha blockers: are all created equal?F M Debruyne
American Journal of Clinical Oncology|January 1, 1988
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancerF M Debruyne
European Urology|January 1, 1996
Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument forF M Debruyne
Urology|January 1, 1991
Anandron: a new step in the treatment of advanced prostate cancerF M Debruyne
Nederlands Tijdschrift Voor Geneeskunde|March 22, 1986
[Kidney stone surgery: still necessary or superfluous?]F M Debruyne
Pathologie-Biologie|October 1, 1990
Epidemiology of the bladder tumorsF M Debruyne
World Journal of Surgery|November 9, 2000
Future of European urologyF M Debruyne
Nederlands Tijdschrift Voor Geneeskunde|April 21, 1990
[Once more kidney stone lithotripsy]F M Debruyne
Tijdschrift Voor Gerontologie En Geriatrie|April 1, 1986
[Urologic tumors in old age]F M Debruyne
Pageof 51

Showing results (1-10 of 505) with videos related to

Sort By:
Pageof 51
World Journal of Urology|June 21, 2002
Future aspects of TUMT treatment of benign prostatic hypertrophyF M Debruyne
Urology|November 14, 2000
Alpha blockers: are all created equal?F M Debruyne
American Journal of Clinical Oncology|January 1, 1988
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancerF M Debruyne
European Urology|January 1, 1996
Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument forF M Debruyne
Urology|January 1, 1991
Anandron: a new step in the treatment of advanced prostate cancerF M Debruyne
Nederlands Tijdschrift Voor Geneeskunde|March 22, 1986
[Kidney stone surgery: still necessary or superfluous?]F M Debruyne
Pathologie-Biologie|October 1, 1990
Epidemiology of the bladder tumorsF M Debruyne
World Journal of Surgery|November 9, 2000
Future of European urologyF M Debruyne
Nederlands Tijdschrift Voor Geneeskunde|April 21, 1990
[Once more kidney stone lithotripsy]F M Debruyne
Tijdschrift Voor Gerontologie En Geriatrie|April 1, 1986
[Urologic tumors in old age]F M Debruyne
Pageof 51